Aclaris Therapeutics Inc (ACRS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ACRS Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Aclaris Therapeutics Inc balances growth, leverage, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent170.60
Available-for-sale Securities, Debt Securities, Current MA223.84
Cash & Short-term Investments393.00
Accounts receivable0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.00
Total Current Assets97.77
Equipment/Property/Plant Net0.66
Long-term investments79.07
Other Assets, Noncurrent2.20
Total Assets179.69
Liabilities
Accounts Payable, Current AC15.52
Accrued Liabilities, Current AC5.96
Other Liabilities, Current4.57
Disposal Group, Including Discontinued Operation, Liabilities, Current LI2.20
Total Current Liabilities28.24
Total Long-term Debt0.00
Other liabilities, Noncurrent26.87
Total Liabilities55.11
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock1,134.00
Retained Earnings / Accumulated Deficit-1,009.11
Accumulated Other Comprehensive Income-0.30
Other Equity-0.30
Common Stockholder's Equity124.58
Total Stockholder's Equity124.58
Liabilities & Stockholder's Equity179.69
4 historic quarters locked

Sign in to unlock the full Aclaris Therapeutics Inc balance sheet history.

About Aclaris Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-092065

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.